Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
For people with relapsed or refractory diffuse large B-cell lymphoma
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Potential of Ayurveda’s contribution in global health system through various innovative practices
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
Subscribe To Our Newsletter & Stay Updated
